As the government’s oldest consumer protection agency, the FDA has long butted up against drugmakers, activists and politicians. But undermining its work could be harmful to patient health and safety.
The legal battle over mifepristone could have far-reaching effects on reproductive health care.
AP Photo/J. Scott Applewhite
The Supreme Court’s ruling on mifepristone keeps the drug accessible for now, but its future is still in limbo.
The Supreme Court is the latest court to take up the question of regulating a medication used for abortions.
Kent Nishimura/Los Angeles Times via Getty Images
If the ruling to reverse the use of mifepristone stands, it will not only severely restrict abortion access for women throughout the US – it will have far-reaching effects on health care.